An Open-label, Fixed-sequence Phase I Clinical Trial to Evaluate the Effect of HS-10504 on the Pharmacokinetics of Midazolam in Patients With Non-small Cell Lung Cancer
Clinical trial NCT07685041 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07685041
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-27
- Primary completion
- 2026-11-19
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.